If transcatheter aortic valve replacement (TAVR) is to be expanded for patients with symptomatic severe aortic stenosis and low surgical risk, 2 critical issues need to be addressed: first, ease… Click to show full abstract
If transcatheter aortic valve replacement (TAVR) is to be expanded for patients with symptomatic severe aortic stenosis and low surgical risk, 2 critical issues need to be addressed: first, ease of coronary access for angiography or percutaneous coronary intervention (PCI), and second, feasibility
               
Click one of the above tabs to view related content.